Researchers have gained impportant new insights into Huntington's disease-a rare genetic, neurodegenerative disorder... | ...

Treatments that target a fragment of the mutant protein that causes Huntington's disease might be more effective than ...

Huntington's disease is a devastating brain disorder that slowly robs people of movement, memory, and personality. It is caused by a toxic protein that builds in brain cells and ultimately kills them.

As the inaugural Director of the new Parkinson's Research Centre, funded by the UK Dementia Research Institute and Parkinson's UK, Professor Miratul Muqit (University of Dundee, UK) hopes to untangle ...

An expert involved in the first successful gene therapy trial for Huntington's Disease discusses the trial results and ...

Abstract: Any problems with the liver, kidney, and heart Can have serious repercussions and increase mortality if neglected. An online healthcare assistance system for the detection of liver, kidney, ...

Kidney damage can sneak up on people without symptoms. A new diagnosis can mean major limits on how a person lives ...

The Alliance was born from a classic D.C. moment: three Illinois advocates, standing in a hallway, waiting to meet with Senator Dick Durbin. That is where Wayne Galasek of Oak Park, Doug Butchart of ...

Neurocrine Biosciences has rebounded 60% since April 2025, driven by robust Ingrezza sales and Crenessity's uncontested launch. Read why NBIX stock is a hold.

The Hunter syndrome space suffered a setback in February when the FDA turned down REGENXBIO's investigational gene therapy, ...

Barclays 28th Annual Global Healthcare Conference March 11, 2026 8:00 AM EDTCompany ParticipantsMatthew Klein - CEO ...

The MarketWatch News Department was not involved in the creation of this content. Industry veteran brings more than 30 years of experience launching therapies for neurological diseases, including ...